Tranexamic Acid 500 MG
Tranexamic Acid 500 MG is a pharmaceutical drug with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.
Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults
ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial
Tranexamic Acid Instillation in Laparoscopic Cholecystectomy
Tranexamic Acid for Anaemia Trial
Clinical Trials (10)
ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.
Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults
ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial
Tranexamic Acid Instillation in Laparoscopic Cholecystectomy
Tranexamic Acid for Anaemia Trial
Tranexamic Acid in Treatment of Facial Erythema
Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty
Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma -2
Treatment of Copper Intra Uterine Device Associated Heavy Menstrual Blood Loss
Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10